Michelle Mollica on Individualizing Care Plans for Cancer Survivors

Video
Conferences|ONS Annual Congress

Michelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.

Childhood cancer survivors may face different challenges than adult or geriatric patients, according to Michelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute (NCI).

Mollica, who is a senior advisor in the NCI Office of Cancer Survivorship and is consequently responsible for developing, supporting, and promoting research efforts focused on cancer survivorship, gave a talk on individualized survivorship care plans at the 47th Annual Oncology Nursing Society Congress.

In an interview with Oncology Nursing News®, Mollica discusses tailoring different plans to fit the needs of different populations.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
Related Content
Anatomical image of a person with the gastrointestinal tract highlighted

Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

Jordyn Sava
June 12th 2025
Article

Lasting survival benefits vs chemotherapy or monotherapy were achieved with nivolumab and ipilimumab for patients MSI-H/ dMMR metastatic colorectal cancer.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Anatomical graphic of a kidney

AI Tool May Predict Response, Resistance in Advanced RCC

Kristie L. Kahl
June 10th 2025
Article

A machine learning model applied to CheckMate 9ER may help predict outcomes and resistance in advanced renal cell carcinoma.

The Vitals

Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

Lindsay Fischer
June 1st 2023
Podcast

Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.

Image of an anatomical figure on a desk of the female reproductive system

Pembrolizumab Plus CCRT Could Become SOC in High-Risk Cervical Cancer

Kristi Rosa
June 8th 2025
Article

Final KEYNOTE-A18 results show sustained survival benefit with pembrolizumab plus concurrent chemoradiation in locally advanced cervical cancer.

Graphic of blood cells

Zilovertamab Vedotin Plus R-GemOx Shows Activity in R/R DLBCL

Silas Inman
June 7th 2025
Article

The ROR1-targeted ADC plus R-GemOx led to a 56.3% ORR in patients with relapsed or refractory diffuse large B-cell lymphoma in waveLINE-003.